Skip to main content
Fig. 2 | Cancer Nanotechnology

Fig. 2

From: Emodin-loaded polymer-lipid hybrid nanoparticles enhance the sensitivity of breast cancer to doxorubicin by inhibiting epithelial–mesenchymal transition

Fig. 2

The effect of Galunisertib combined with DOX on cell proliferation and invasion. Cell viability of MCF-7/ADR cells after treatment with different Galunisertib concentration (27.9–1000 μM). B, C The effect of 30 μM Galunisertib on the expression of EMT marker protein. N = 3, **p < 0.01, ***p < 0.001 compared with Control group. D Cell viability on MCF-7/ADR cells after treatment with 30 μM Galunisertib combined with DOX of different concentrations (1.56–200 μM). E, F The invasion activity of MCF-7/ADR cells after incubation with DOX (10 μM), Galunisertib (30 μM), DOX (10 μM) + Galunisertib (30 μM) over 48 h. N = 3, **p < 0.01, ***p < 0.001 compared with DOX group

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us